Overview
This educational activity will focus on the main aspects of ART The program will start with the low prognosis patients, focusing on the diagnostic assessment of the condition and its management.; then, the lectures will be focused on the management of other aspects of ART treatment, defining the clinical applicability through the real-world data availability.
The program will take place in Asia Pacific and Europe and will engage renowned international and regional experts with vast clinical experience in constantly evolving subjects.
Learning Objectives
After attending the educational activities, learners will be able to:
- • Define severe LH and FSH deficiency and patient management.
- • Discuss and debate the management of low prognosis patients.
- • Define the role of Pharmacogenetics in COS and explore recurrent implantation failures
- • Comprehend the new low prognosis concept and its application in clinical practice.
- • Individualize and manage women with expected or unexpected prognosis to ART as per the POSEIDON classification.
- • Evaluate luteal phase supplementations in fresh and frozen cycles.
- • Estimate pregnancy outcomes in the freeze-all strategy.
Target Audience
The program is intended for clinicians, embryologists, andrologists, scientists, and managers working in ART who wish to update their knowledge of advanced techniques and scientific innovations and understand best practices using evidence-based models of care.
Accreditation
Improve the chances of a successful pregnancy Brussels, Belgium, 11/11/2023-11/11/2023 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®)
for a maximum of 5 European CME credits (ECMEC®s).
Venue 11 November 2023
Radisson Collection Hotel, Grand Place Brussels
47 Rue du Fossé aux Loups, Brussels,1000,Belgium
Language
The official language of the activity will be English
Nominal Sponsor
Partnership
Association of Reproductive Medicine and Surgery (ARMS)
POSEIDON – Patient Oriented Strategies Encompassing IndividualizeD Oocyte Number
Algerian Society of Reproductive Medicine (SAMERE)
Brazilian Association of Assisted Reproduction (SBRA)
Spanish Fertility Society (SEF)
Italian Society of Fertility and Sterility (SIFES)
Improve the chances of a successful pregnancy
Hybrid Workshop
Europe - Asia Pacific
1st workshop: 15 April 2023 Singapore, Republic of Singapore
2nd Workshop: 11 November 2023-Brussels, Belgium
Date & Venue
11 November 2023
Brussels, Belgium
Online FREE live streaming registration
Chairs
International Committee
Habib Midassi
Sfax, Tunisia
Fertility Group of the STGO (Tunisian Society of obstetrics and gynecology)
Sfax, Tunisia
Faculty 1st Workshop
15 April 2023
Faculty 2nd Workshop
11 November 2023
Scientific program
From 09.00 to 16.20
Central European Time (CET)
09.00 MedEA Welcome and introduction
Robert Fischer, Germany
09.05 Local welcome
Christophe Blockeel, Belgium
09.10 Workshop introduction
Carlo Alviggi, Italy
09.15 L1 – Low prognosis patient’s introduction to the POSEIDON criteria
Robert Fischer, Germany
09.40 L2 -Management strategies in POSEIDON group 1 and 2 patients (LH FSH deficiency)
Carlo Alviggi, Italy
10.05 L3 – Management strategies in POSEIDON group 3 and 4 patients
Robert Fischer, Germany
10.30 Discussion
11.00 Coffee break
11.20 L4 – The role of pharmacogenetic in ART
Carlo Alviggi, Italy
11.45 L5 – Managing a good prognosis patient
To be announced
12.00 L6 – Duo Stim to Optimize Number of Oocytes and Time to pregnancy in Low Prognosis Patients
Alberto Vaiarelli, Italy
12.25 Discussion
13.00 Lunch
14.00 L7 –Luteal phase supplementations in fresh and frozen cycles
Alberto Vaiarelli, Italy
14.25 L8 – Recurrent implantation failure definition diagnosis and management
Hakan Yarali, Turkey
14.50 Discussion
15.10 Coffee break
15.30 L9 – Freeze all strategy – for all patients?
Christophe Blockeel, Belgium
15.55 Discussion
16.20 Closing remarks
Robert Fischer, Germany; Carlo Alviggi, Italy; Christophe Blockeel, Belgium
From 09.00 to 16.20
Singapore Time (SGT)
Agenda: Singapore Time (SGT)
09.00 MedEA Welcome and introduction
Robert Fischer, Germany
09.05 Local welcome
PC Wong, Singapore
09.10 Workshop introduction
Carlo Alviggi, Italy
09.15 L1 – Low prognosis patient’s introduction to the POSEIDON criteria
Robert Fischer, Germany
09.40 L2 -Management strategies in POSEIDON group 1 and 2 patients
Carlo Alviggi, Italy
10.05 L3 – Management strategies in POSEIDON group 3 and 4 patients
Robert Fischer; Germany
10.30 Discussion
11.00 Coffee break
11.20 L4 – Managing a good prognosis patient
Andrew Kan, Australia
11.45 L5 – Defining severe LH and FSH deficiency and patients management
Zhongwei Huang, Singapore
12.00 L6 – Duo Stim to Optimize Number of Oocytes and Time to pregnancy in Low Prognosis Patients
Carlo Alviggi, Italy
12.25 Discussion
13.00 Lunch
14.00 L7 – Luteal phase supplementations in fresh and frozen cycles
Su Ling Yu, Singapore
14.25 L8 – Redefining PCOS and management strategies
Andrew Kan, Australia
14.50 Discussion
15.10 Coffee break
15.30 L9 – Freeze all strategy – for all patients?
Zhongwei Huang, Singapore
15.55 Discussion
16.20 Closing remarks
Robert Fischer, Carlo Alviggi, PC Wong
Registration
Onsite Registration:
CLICK ABOVE for registration, accommodation and any logistic inquiry.
Standard registration fee: 200.00€ (+22%VAT) **
Reduced fees for members of affiliated Scientific Societies*: 150.00€ (+22%VAT) **
Reduced fees: 100.00€ (+22%VAT) ** for residents and fellows in training.
The registration includes:
• Scientific sessions
• Coffee breaks and lunch
• Educational materials
• Certificate of attendance
* Association of Reproductive Medicine and Surgery (ARMS); POSEIDON – Patient Oriented Strategies Encompassing IndividualizeD Oocyte Number; Algerian Society of Reproductive Medicine (SAMERE); Brazilian Association of Assisted Reproduction (SBRA); Spanish Fertility Society (SEF); Italian Society of Fertility and Sterility (SIFES); Portuguese Society of Reproductive Medicine (SPMR); Tunisian Society of Gynecology and Obstetrics (STGO)
** For payment with Credit Card a fee will be applied.